Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Июль 8, 2024
Background
Pathomics
has
emerged
as
a
promising
biomarker
that
could
facilitate
personalized
immunotherapy
in
lung
cancer.
It
is
essential
to
elucidate
the
global
research
trends
and
emerging
prospects
this
domain.
Methods
The
annual
distribution,
journals,
authors,
countries,
institutions,
keywords
of
articles
published
between
2018
2023
were
visualized
analyzed
using
CiteSpace
other
bibliometric
tools.
Results
A
total
109
relevant
or
reviews
included,
demonstrating
an
overall
upward
trend;
terms
“deep
learning”,
“tumor
microenvironment”,
“biomarkers”,
“image
analysis”,
“immunotherapy”,
“survival
prediction”,
etc.
are
hot
field.
Conclusion
In
future
endeavors,
advanced
methodologies
involving
artificial
intelligence
pathomics
will
be
deployed
for
digital
analysis
tumor
tissues
microenvironment
cancer
patients,
leveraging
histopathological
tissue
sections.
Through
integration
comprehensive
multi-omics
data,
strategy
aims
enhance
depth
assessment,
characterization,
understanding
microenvironment,
thereby
elucidating
broader
spectrum
features.
Consequently,
development
multimodal
fusion
model
ensue,
enabling
precise
evaluation
efficacy
prognosis
potentially
establishing
pivotal
frontier
domain
investigation.
Journal of Cancer Research and Clinical Oncology,
Год журнала:
2024,
Номер
150(2)
Опубликована: Фев. 5, 2024
Abstract
Purpose
Bone
metastasis
is
a
significant
contributor
to
morbidity
and
mortality
in
advanced
prostate
cancer,
early
diagnosis
challenging
due
its
insidious
onset.
The
use
of
machine
learning
obtain
prognostic
information
from
pathological
images
has
been
highlighted.
However,
there
limited
understanding
the
potential
prediction
bone
through
feature
combination
method
various
sources.
This
study
presents
integrating
multimodal
data
enhance
feasibility
cancer.
Methods
materials
Overall,
211
patients
diagnosed
with
cancer
(PCa)
at
Gansu
Provincial
Hospital
between
January
2017
February
2023
were
included
this
study.
randomized
(8:2)
into
training
group
(
n
=
169)
validation
42).
region
interest
(ROI)
segmented
three
magnetic
resonance
imaging
(MRI)
sequences
(T2WI,
DWI,
ADC),
features
extracted
tissue
sections
(hematoxylin
eosin
[H&E]
staining,
10
×
20).
A
deep
(DL)
model
using
ResNet
50
was
employed
extract
transfer
(DTL)
features.
least
absolute
shrinkage
selection
operator
(LASSO)
regression
utilized
for
selection,
construction,
reducing
dimensions.
Different
classifiers
used
build
predictive
models.
performance
models
evaluated
receiver
operating
characteristic
curves.
net
clinical
benefit
assessed
decision
curve
analysis
(DCA).
goodness
fit
calibration
joint
nomogram
eventually
developed
by
combining
clinically
independent
risk
factors.
Results
best
based
on
DTL
pathomics
showed
area
under
(AUC)
values
0.89
(95%
confidence
interval
[CI],
0.799–0.989)
0.85
CI,
0.714–0.989),
respectively.
AUC
radiomics
features,
0.86
0.735–0.979)
0.93
0.854–1.000),
Based
DCA
curves,
demonstrated
good
fit.
Conclusion
Multimodal
serve
as
valuable
predictors
metastases
primary
PCa.
Pharmaceutics,
Год журнала:
2025,
Номер
17(1), С. 97 - 97
Опубликована: Янв. 13, 2025
Background:
The
mechanism
of
Dendrobium
officinale
polysaccharide-based
nanocarriers
in
enhancing
photodynamic
immunotherapy
colorectal
cancer
(CRC)
remains
poorly
understood.
Methods:
effects
TPA-3BCP-loaded
cholesteryl
hemisuccinate–Dendrobium
polysaccharide
nanoparticles
(DOP@3BCP
NPs)
and
their
potential
molecular
action
a
tumor-bearing
mouse
model
CRC
were
investigated
using
non-targeted
metabolomics
transcriptomics.
Meanwhile,
histopathological
analysis
(H&E
staining,
Ki67
TUNEL
assay)
qRT-PCR
revealed
the
antitumor
DOP@3BCP
NPs
with
without
light
activation.
Results:
Through
transcriptomics
analysis,
we
found
an
alteration
metabolome
functional
pathways
examined
tumor
tissues.
metabolic
showed
69
60
differentially
expressed
metabolites
(DEMs)
positive-
negative-ion
modes,
respectively,
treated
samples
compared
to
Control
samples.
that
1352
genes
among
three
groups.
regulated
primally
related
immune
response.
results
pathological
histology
assay
verified
findings
integrated
analysis.
Conclusions:
Overall,
our
elucidate
mechanisms
D.
nanocarrier
CRC.
Cancers,
Год журнала:
2025,
Номер
17(3), С. 478 - 478
Опубликована: Фев. 1, 2025
Background/Objectives:
Tumor
interactions
with
their
surrounding
environment,
particularly
in
the
case
of
peritumoral
edema,
play
a
significant
role
tumor
behavior
and
progression.
While
most
studies
focus
on
radiomic
features
core,
this
work
investigates
whether
edema
exhibits
distinct
fingerprints
specific
to
glioma
(GLI),
meningioma
(MEN),
metastasis
(MET).
By
analyzing
these
patterns,
we
aim
deepen
our
understanding
microenvironment’s
development
Methods:
Radiomic
were
extracted
from
regions
T1-weighted
(T1),
post-gadolinium
(T1-c),
T2-weighted
(T2),
T2
Fluid-Attenuated
Inversion
Recovery
(T2-FLAIR)
sequences.
Three
classification
tasks
using
those
then
conducted:
differentiating
between
Low-Grade
Glioma
(LGG)
High-Grade
(HGG),
distinguishing
GLI
MET
MEN,
examining
all
four
types,
i.e.,
LGG,
HGG,
MET,
observe
how
tumor-specific
signatures
manifest
edema.
Model
performance
was
assessed
balanced
accuracy
derived
10-fold
cross-validation.
Results:
The
types
more
T1-c
images
compared
other
modalities.
best
models,
utilizing
images,
achieved
accuracies
0.86,
0.81,
0.76
for
LGG-HGG,
GLI-MET-MEN,
LGG-HGG-MET-MEN
tasks,
respectively.
Conclusions:
This
study
demonstrates
that
as
characterized
by
MRIs,
contains
type,
providing
non-invasive
approach
tumor-brain
interactions.
results
hold
potential
predicting
recurrence,
progression
pseudo-progression,
assessing
treatment-induced
changes,
gliomas.
Metabolites,
Год журнала:
2025,
Номер
15(3), С. 201 - 201
Опубликована: Март 13, 2025
Background:
Tumor
cells
engage
in
continuous
self-replication
by
utilizing
a
large
number
of
resources
and
capabilities,
typically
within
an
aberrant
metabolic
regulatory
network
to
meet
their
own
demands.
This
dysregulation
leads
the
formation
tumor
microenvironment
(TME)
most
solid
tumors.
Nanomedicines,
due
unique
physicochemical
properties,
can
achieve
passive
targeting
certain
tumors
through
enhanced
permeability
retention
(EPR)
effect,
or
active
deliberate
design
optimization,
resulting
accumulation
TME.
The
use
nanomedicines
target
critical
pathways
holds
significant
promise.
However,
requires
careful
selection
relevant
drugs
materials,
taking
into
account
multiple
factors.
traditional
trial-and-error
process
is
relatively
inefficient.
Artificial
intelligence
(AI)
integrate
big
data
evaluate
delivery
efficiency
nanomedicines,
thereby
assisting
nanodrugs.
Methods:
We
have
conducted
detailed
review
key
papers
from
databases,
such
as
ScienceDirect,
Scopus,
Wiley,
Web
Science,
PubMed,
focusing
on
reprogramming,
mechanisms
action
development
metabolism,
application
AI
empowering
nanomedicines.
integrated
content
present
current
status
research
metabolism
potential
future
directions
this
field.
Results:
Nanomedicines
possess
excellent
TME
which
be
utilized
disrupt
cells,
including
glycolysis,
lipid
amino
acid
nucleotide
metabolism.
disruption
selective
killing
disturbance
Extensive
has
demonstrated
that
AI-driven
methodologies
revolutionized
nanomedicine
development,
while
concurrently
enabling
precise
identification
molecular
regulators
involved
oncogenic
reprogramming
pathways,
catalyzing
transformative
innovations
targeted
cancer
therapeutics.
Conclusions:
great
Additionally,
will
accelerate
discovery
metabolism-related
targets,
empower
optimization
help
minimize
toxicity,
providing
new
paradigm
for
development.
To
extract
intratumoral,
peritumoral,
and
integrated
intratumoral-peritumoral
CT
radiomic
features,
develop
multi-source
models
using
various
machine
learning
algorithms
to
identify
the
optimal
model,
integrate
clinical
factors
establish
a
nomogram
for
predicting
therapeutic
response
induction
therapy(IT)
in
locally
advanced
non-small
cell
lung
cancer.
This
study
included
209
patients
with
cancer
(LA-NSCLC)
who
received
IT
as
training
cohort,
an
external
validation
cohort
comprising
50
from
another
center.
Radiomic
features
were
extracted
regions
by
manually
delineating
gross
tumor
volume
(GTV)
additional
3
mm
surrounding
area.
Three
algorithms—Support
Vector
Machine
(SVM),
XGBoost,
Gradient
Boosting—were
employed
construct
each
region.
Model
performance
was
evaluated
metrics
such
Area
Under
Curve
(AUC),
confusion
matrix,
accuracy,
precision,
recall,
F1
score.
Finally,
comprehensive
integrating
model
independent
predictors
developed.
Through
comparison
of
algorithms,
INTRAPERI,
INTRA,
PERI
achieved
best
Boosting,
SVM,
respectively.
Compared
INTRA_SVM
PERI_XGBoost
INTRA
models,
fusion
that
integrates
peritumoral
within
margin
around
(INTRAPERI_GradientBoosting)
showed
better
predictive
set,
AUCs
93.7%,
82.5%,
89.4%,
In
PS
score
identified
factor.
The
combining
INTRAPERI_GradientBoosting
demonstrated
value.
which
intra-tumoral
performs
than
radiomics
efficacy
therapy
LA-NSCLC.
Additionally,
based
on
INTRAPERI
combined
has
Neurospine,
Год журнала:
2025,
Номер
22(1), С. 144 - 156
Опубликована: Март 31, 2025
Objective:
This
study
investigates
the
potential
of
radiomics
to
predict
postoperative
progression
ossification
posterior
longitudinal
ligament
(OPLL)
after
cervical
spine
surgery.Methods:
retrospective
included
473
patients
diagnosed
with
OPLL
at
Peking
University
Third
Hospital
between
October
2006
and
September
2022.
Patients
underwent
spinal
surgery
had
least
2
computed
tomography
(CT)
examinations
spaced
1
year
apart.
was
defined
as
an
annual
growth
rate
exceeding
7.5%.
Radiomic
features
were
extracted
from
preoperative
CT
images
lesions,
followed
by
feature
selection
using
correlation
coefficient
analysis
absolute
shrinkage
operator,
dimensionality
reduction
principal
component
analysis.
Univariable
identified
significant
clinical
variables
for
constructing
model.
Logistic
regression
models,
including
Rad-score
model,
combined
developed
progression.Results:
Of
patients,
191
(40.4%)
experienced
progression.
On
testing
set,
which
incorporated
(area
under
receiver
operating
characteristic
curve
[AUC]
=
0.751),
outperformed
both
radiomics-only
model
(AUC
0.693)
0.620).
Calibration
curves
demonstrated
good
agreement
predicted
probabilities
observed
outcomes,
decision
confirmed
utility
SHAP
(SHapley
Additive
exPlanations)
indicated
that
age
key
contributors
model’s
predictions,
enhancing
interpretability.Conclusion:
Radiomics,
variables,
provides
a
valuable
predictive
tool
assessing
risk
in
OPLL,
supporting
more
personalized
treatment
strategies.
Prospective,
multicenter
validation
is
needed
confirm
broader
settings.